Dr. Sampson focuses on the design and analysis of studies evaluating genetic, metabolomic, and epidemiologic associations with cancer.
With his background in statistics and biology, Dr. Sampson has developed an innovative research portfolio in molecular epidemiology and made key contributions to numerous studies. Since joining the Division, he has introduced new study designs to improve the efficiency of next-generation sequencing, developed a testing framework for identifying associations with groups of rare single nucleotide polymorphisms, and designed new methods for analyzing subgroup-specific genetic effects.